Each year, RSV results in millions of outpatient visits for young children, tens of thousands of hospitalizations among children and adults aged 65 and older, and thousands of deaths. This winter ...

More information: Yi-Zong Lee et al, Rational design of uncleaved prefusion-closed trimer vaccines for human respiratory ...

New research discussed the structure and life cycle of respiratory syncytial virus (RSV), the current research on the treatment and prevention of RSV infections, and the advancements in RSV mRNA ...

The words respiratory syncytial virus (RSV) can strike fear into the ... “Pfizer took the structure of this protein, stabilized it, and made it into a bivalent subunit vaccine.

Respiratory syncytial virus (RSV) is one of the main reasons leading to hospitalisation among young children worldwide and each year, ... change in age structure and less severe illness ...

Respiratory syncytial virus (RSV) is one of the main reasons leading to hospitalization among young children worldwide and each year, an estimated 101,000 children below the age of 5 years die due ...

Pfizer’s vaccine to protect newborns from respiratory syncytial virus, or RSV, by vaccinating their moms late in pregnancy cuts the risk that infants will need to see a doctor or be admitted to ...

Respiratory Syncytial Virus or RSV is one of the most common respiratory viruses circulating today. Often thought of as only being dangerous to babies and toddlers due to how often child-related ...

Respiratory Syncytial Virus (RSV) is a major health concern affecting millions each year. From the first sniffle to serious complications, understanding RSV is crucial, especially for vulnerable ...

Respiratory syncytial virus (RSV) causes symptoms similar to the common cold. But in older adults and those with certain medical conditions, the virus can increase the risk of serious illnesses. A ...